Adjuvant Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) Associated with Curative Surgery for Locally Advanced Gastric Carcinoma. An Initial Experience

Abstract

Aggressive surgical therapy and HIPEC might represent the standard of care in a selected population with locoregional disease and for whom a R0 resection can be achieved. This protocol was associated in this study with a 75% 5-year survival with a low peritoneal recurrence rate and an acceptable morbidity.